Compare TAP & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAP | ELAN |
|---|---|---|
| Founded | 1873 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 10.3B |
| IPO Year | N/A | 2018 |
| Metric | TAP | ELAN |
|---|---|---|
| Price | $47.32 | $22.23 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 10 |
| Target Price | ★ $51.47 | $23.11 |
| AVG Volume (30 Days) | 2.9M | ★ 5.9M |
| Earning Date | 02-12-2026 | 11-05-2025 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $11,214,000,000.00 | $4,591,000,000.00 |
| Revenue This Year | N/A | $7.25 |
| Revenue Next Year | N/A | $5.73 |
| P/E Ratio | ★ N/A | $319.59 |
| Revenue Growth | N/A | ★ 3.08 |
| 52 Week Low | $42.94 | $8.02 |
| 52 Week High | $64.66 | $23.70 |
| Indicator | TAP | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 54.76 | 51.13 |
| Support Level | $45.91 | $21.95 |
| Resistance Level | $48.69 | $23.06 |
| Average True Range (ATR) | 0.92 | 0.51 |
| MACD | -0.05 | 0.04 |
| Stochastic Oscillator | 59.38 | 60.14 |
Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling and ranks as the second-largest beer maker in both value and volume terms in the US, Canada, and the United Kingdom. Through licensing agreements, the firm also brews and distributes beer and hard seltzer under partner brands from Heineken, Anheuser-Busch InBev, Asahi, and Coca-Cola. The brewer uses independent distributors in the US, given the three-tier distribution requirements, while using a combination of distributors and an in-house sales team in Canada and Europe. North America remains its largest market, contributing over 80% of total revenue.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.